The amino acid sequence of Retatrutide is His(Aib)QGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 with C18 fatty acid at Lys30
It activates two of the same three receptors (GLP-1 and GIP), missing only the glucagon pathway
Until that happens, the safest course is to avoid purchasing it from unregulated online sources and instead work with a qualified medical team who can guide you toward safe, proven options
Notably, only one registered clinical study exists to date, which evaluates an implant-based delivery system of Exenatide and is currently in Phase 1 with an Active, not recruiting status (NCT05670379), initiated on December 20, 2024, and expected to conclude by August 2025
AI disclosure The authors did not use generative AI in the preparation of this work